𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suppression of mitogen-activated protein kinase phosphatase-1 (MKP-1) by heparin in vascular smooth muscle cells

✍ Scribed by Yong Zhao; Weiqun Xiao; Douglas M. Templeton

Book ID
113993625
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
308 KB
Volume
66
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of mitogen-activated protein
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma
✍ Carsten Denkert; Wolfgang D. Schmitt; Stefan Berger; Angela Reles; SΓΆren Pest; A πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 900 KB

## Abstract The mitogen‐activated protein kinase phosphatase‐1, MKP‐1 (CL100) is involved in inactivation of MAP‐kinase pathways, regulation of stress‐responses and suppression of apoptosis. We investigated expression of MKP‐1 in 90 cases of primary ovarian tumors, 11 normal ovaries as well as 4 ov

Heparin treatment of vascular smooth mus
Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1
✍ Cheryl Isleib Blaukovitch; Raymond Pugh; Albert C. Gilotti; Daniela Kanyi; Linda πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 264 KB

## Abstract The ability of heparin to block proliferation of vascular smooth muscle cells has been well documented. It is clear that heparin treatment can decrease the level of ERK activity in vascular smooth muscle cells that are sensitive to heparin. In this study, the mechanism by which heparin